Suministro de los principios activos denominados "ODEVIXIBAT 1200 MCG" Y "LANREOTIDA 60 MG IM SC" para el Hospital Universitario de Gran Canaria Dr. Negrín.
TED · 322579-2026Award noticeawardedNo deadline given
Buyer
NameDirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
CountryES
Published2026-05-11
Deadline—
Who already wins at this buyer
Firms with recorded awards from Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| IPSEN PHARMA, S.A.U. | 1 | €595,637 | 2026-06-18 |
| SWEDISH ORPHAN BIOVITRUM S.L | 1 | €403,705 | 2026-05-27 |
| MERCK SHARP & DOHME ESPAÑA, S.A. | 1 | €332,277 | 2026-05-11 |
| ROCHE FARMA, S.A. | 1 | €305,648 | 2026-07-13 |
| PFIZER, S.L. | 1 | €249,425 | 2026-06-09 |
CPV codes
33690000 Medical equipment & pharmaceuticalsDescription
El objeto del contrato viene determinado por el suministro de los principios activos denominados "ODEVIXIBAT 1200 MCG" Y"LANREOTIDA 60 MG IM SC" para el Hospital Universitario de Gran Canaria Dr. Negrín.
Similar tenders
Closest by meaning — across languages, via embeddings.